NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rectal Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: This is a two staged, single arm phase II trial of chemotherapy (FOLFOX or CAPOX) followed by tumour excision in patients with early stage rectal cancerMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03259035
- Collaborators
- Not Provided
- Investigators
- Study Chair: Hagen Kennecke Virginia Mason Medical Centre, WA USA Study Chair: Carl Brown St. Paul's Hospital, Vancouver BC
Get Well Soon